Envestnet Asset Management Inc Bridge Bio Pharma, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 12,926 shares of BBIO stock, worth $416,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,926
Previous 15,875
18.58%
Holding current value
$416,087
Previous $404,000
12.38%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$813 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$809 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$401 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$199 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.77B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...